Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Actelion Pharmaceuticals synthesizes novel orexin receptor antagonists

June 8, 2012

Spanish scientists discover new integrin antagonists

June 8, 2012

U.S. team presents new products for cancer and other disorders

June 7, 2012

Novel S1P1 receptor agonists discovered by Bristol-Myers Squibb

June 7, 2012

Spanish researchers prepare novel stable atomic quantum clusters

June 7, 2012

Researchers at Celgene report new inhibitors of mutant EGFR

June 7, 2012

New PI3K inhibitors developed by Bayer Schering Pharma

June 7, 2012

Novel candidate anticancer drugs patented by Portola Pharmaceuticals

June 7, 2012

Novel protein kinase inhibitors divulged

June 6, 2012

Research at U.S. university yields new anticancer agents

June 6, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.